Shopping Cart
Remove All
Your shopping cart is currently empty
6RK73 is a covalent, irreversible, and specific UCHL1 inhibitor (IC50: 0.23 µM) with almost no inhibition of UCHL3 (IC50: 236 µM).

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $147 | In Stock | In Stock | |
| 5 mg | $313 | In Stock | In Stock | |
| 10 mg | $537 | In Stock | In Stock | |
| 25 mg | $869 | In Stock | In Stock | |
| 50 mg | $1,190 | In Stock | In Stock | |
| 100 mg | $1,590 | In Stock | In Stock | |
| 500 mg | $3,220 | - | In Stock | |
| 1 mL x 10 mM (in DMSO) | $345 | In Stock | In Stock |
| Description | 6RK73 is a covalent, irreversible, and specific UCHL1 inhibitor (IC50: 0.23 µM) with almost no inhibition of UCHL3 (IC50: 236 µM). |
| Targets&IC50 | UCHL3:236 µM , UCHL1:0.23 µM |
| In vitro | 6RK73 (5 µM; 1-3 hours) treatment displays strong inhibition of the TGFβ-induced pSMAD2 and pSMAD3, and a decrease of TβRI and total SMAD protein levels in MDA-MB-436 cells. 6RK73 (5 µM; 24-48 hours) results in migration significantly slower than the DMSO control group in MDA-MB-436 cells[1]. |
| In vivo | 6RK73 displays a potent inhibition of breast cancer extravasation in zebrafish[1]. |
| Cell Research | Cell Line: MDA-MB-436 cells Concentration: 5 µM Incubation Time: 24, 48 hours |
| Molecular Weight | 307.37 |
| Formula | C13H17N5O2S |
| Cas No. | 1895050-66-4 |
| Smiles | O=C(Nc1ncc(s1)N1CCOCC1)[C@H]1CCN(C1)C#N |
| Relative Density. | 1.41 g/cm3 (Predicted) |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 112.5 mg/mL (366 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
| In Vivo Formulation | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 4 mg/mL (13.01 mM), Sonication is recommended. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.